Czerwinski Michal, Grabarczyk Piotr, Stepien Malgorzata, Kubicka-Russel Dorota, Tkaczuk Katarzyna, Brojer Ewa, Rosinska Magdalena
Department of Epidemiology, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland.
Department of Virology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Transfusion. 2017 Aug;57(8):1998-2006. doi: 10.1111/trf.14163. Epub 2017 May 28.
Since the introduction of nucleic acid testing (NAT) for routine blood donor screening, hepatitis C virus (HCV) RNA-only detection rates reported from Poland have been higher than in most other European countries.
To examine factors that likely contribute to these window-period donations, we conducted a case-control study among 47 recently HCV-infected blood donors (cases), who gave blood between July 2002 and June 2014, and 141 controls matched by age, sex, and donation dates. Firth-corrected, conditional logistic regression models were fitted to estimate adjusted odds ratios and 95% confidence intervals. Adjusted population-attributable fractions were calculated based on the distribution of exposure among the cases.
On multivariate analysis, recent exposures in health care environments not routinely ascertained through predonation questionnaires were strongly associated with recently acquired HCV infection. These exposures included minor medical and dental procedures in the preceding 6 months (adjusted odds ratio, 5.77; 95 % confidence interval, 2.01-18.53). However, based on the population-attributable fraction, more important were behavioral deferrable risks that went unreported at the time of donation, such as high-risk sexual behaviors in the preceding 6 months (population-attributable fraction, 34%) or lifetime histories of drug use (population-attributable fraction, 28%).
This study raises questions about the effectiveness of deferral policy in excluding high-risk individuals. In addition, it provides further evidence supporting short, temporal deferrals for small medical procedures and dental treatments in Poland.
自将核酸检测(NAT)用于常规献血者筛查以来,波兰报告的仅丙肝病毒(HCV)RNA检测率高于大多数其他欧洲国家。
为研究可能导致这些窗口期献血的因素,我们对47名近期感染HCV的献血者(病例组)进行了病例对照研究,这些献血者于2002年7月至2014年6月期间献血,以及141名按年龄、性别和献血日期匹配的对照组。采用Firth校正的条件逻辑回归模型来估计调整后的比值比和95%置信区间。根据病例组中暴露的分布计算调整后的人群归因分数。
多变量分析显示,通过献血前问卷未常规确定的近期在医疗环境中的暴露与近期获得的HCV感染密切相关。这些暴露包括前6个月内的小型医疗和牙科手术(调整后的比值比为5.77;95%置信区间为2.01 - 18.53)。然而,基于人群归因分数,更重要的是献血时未报告的行为可推迟风险,例如前6个月内的高危性行为(人群归因分数为34%)或终身吸毒史(人群归因分数为28%)。
本研究对延期政策在排除高危个体方面的有效性提出了疑问。此外,它提供了进一步的证据支持波兰对小型医疗手术和牙科治疗进行短期、临时性延期。